Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Idiopathic Parkinson Disease

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, M; Hashimoto, M; Sekigawa, A; Sekiyama, K; Waragai, M; Wei, J1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Idiopathic Parkinson Disease

ArticleYear
Gangliosides' protection against lysosomal pathology of synucleinopathies.
    Autophagy, 2009, Volume: 5, Issue:6

    Topics: Autophagy; Cell Line, Tumor; Gangliosides; Humans; Intracellular Membranes; Lewy Body Disease; Lysosomes; Morpholines; Parkinson Disease; Permeability; Protective Agents; Synucleins

2009